1 Glynne-Jones R,Wyrwicz L,Tiret E,et al.Rectal cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2018,29(Suppl 4):263. 2 Thong DW,Kim J,Naik A,et al.Delay to adjuvant chemotherapy:survival and recurrence in patients of rectal cancer treated with neo-adjuvant chemoradiotherapy and surgery[J].J Gastrointest Cancer,2019[Epub ahead of print]. 3 Kim TH,Jeong SY,Choi DH,et al.Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection[J].Ann Surg Oncol,2008,15(3):729-737. 4 Matsuda T,Sumi Y,Yamashita K,et al.Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer[J].Intl J Colorectal Dis,2018,33(4):367-374. 5 Oh HK,Kang SB,Lee SM,et al.Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement:a multicenter retrospective cohort study[J].Ann Surg Oncol,2014,21(7):2280-2287. 6 Akiyoshi T,Matsueda K,Hiratsuka M,et al.Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer[J].Ann Surg Oncol,2015,22(3):614-620. 7 Schaap DP,Ogura A,Nederend J,et al.Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer[J].Br J Surg,2018,105(13):1844-1852. 8 Kusters M,Slater A,Muirhead R,et al.What to do with lateral nodal disease in low locally advanced rectal cancer a call for further reflection and research[J].Dis Colon Rectum,2017,60(6):577-585. 9 Georgiou P,Tan E,Gouvas N,et al.Extended lymphadenectomy versus conventional surgery for rectal cancer:a meta-analysis[J].Lancet Oncol,2009,10(11):1053-1062. 10 陈致奋.AJCC与JSCCR 对直肠癌盆腔侧方淋巴结定义演变的解读[J].中国普通外科杂志,2019,28(4):387-391. 11 Fung DTL,Lee PJM.Update on indications for lateral lymph node dissection in the management of lower rectal cancer[J].ANZ J Surg,2020[Epub ahead of print]. 12 Ahmadi N,Brown KGM,Lee P,et al.Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes[J].Colorectal Dis,2020[Epub ahead of print]. 13 Watanabe T,Itabashi M,Shimada Y,et al.Japanese Society for Cancer of the Colon and Rectum(JSCCR)Guidelines 2014 for treatment of colorecta cancer[J].Int J Clin Oncol,2015,20(2):207-239. 14 Watanabe T,Muro K,Ajioka Y,et al.Japanese Society for Cancer of the Colon and Rectum(JSCCR)guidelines 2016 for the treatment of colorectal cancer[J].Int J Clin Oncol,2018,23(1):1-34. 15 Fujita S,Akasu T,Mizusawa J,et al.Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer(JCOG0212):results from a multicentre,randomised controlled,non-inferiority trial[J].Lancet Oncol,2012,13(6):616-621. 16 Ito M,Kobayashi A,Fujita S,et al.Urinary dysfunction after rectal cancer surgery:results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer(Japan Clinical Oncology Group Study,JCOG0212)[J].Eur J Surg Oncol,2018,44(4):463-468. 17 Yang X,Gu C,Hu T,et al.Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe[J].ANZ J Surg,2019,89(11):492-497. 18 Yamaguchi T,Konishi T,Kinugasa Y,et al.Laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer:a subgroup analysis of a large multicenter cohort study in Japan[J].Dis Colon Rectum,2017,60(9):954-964. 19 Matsuda T,Hasegawa H,Yamashita K,et al.Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy[J].Surg Endosc,2020,34(3):1425-1431. 20 Kawai K,Hata K,Tanaka T,et al.Learning curve of robotic rectal surgery with lateral lymph node dissection:Cumulative sum and multiple regression analyses[J].J Surg Educ,2018,75(6):1598-1605. 21 Malakorn S,Ouchi A,Sammour T,et al.Robotic lateral pelvic lymph node dissection after neoadjuvant chemoradiation:view from the West[J].Dis Colon Rectum,2018,61(9):1119-1120. 22 Hoshino N,Murakami K,Hida K,et al.Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer:a systematic review and meta-analysis[J].Int J Clin Oncol,2019,24(1):46-52. 23 Ishihara S,Kawai K,Tanaka T,et al.Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy[J].ANZ J Surg,2018,88(12):1306-1310. 24 Park BK,Lee SJ,Hur BY,et al.Feasibility of selective lateral node dissection based on magnetic resonance imaging in rectal cancer after preoperative chemoradiotherapy[J].J Surg Res,2018,232:227-233. 25 Ishibe A,Ota M,Watanabe J,et al.Prediction of lateral pelvic lymph node metastasis in low rectal cancer by magnetic resonance imaging[J].World J Surg,2016,40(4):995-1001. 26 Kim MJ,Hur BY,Lee ES,et al.Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy:Focus on MR imaging findings[J].PLoS One,2018,13(4):e0195815. 27 Amano K,Fukuchi M,Kumamoto K,et al.Pre-operative evaluation of lateral pelvic lymph node metastasis in lower rectal cancer:comparison of three different imaging modalities[J].J Anus Rectum Colon,2020,4(1):34-40. 28 Lee JY,Yoon SM,Kim JT,et al.Diagnostic and prognostic value of preoperative(18)F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer:comparison with conventional computed tomography[J].Intest Res,2017,15(2):208-214. 29 Ishihara S,Kawai K,Tanaka T,et al.Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherap[J].Tech Coloproctol,2018,22(5):347-354. |